Viniferin

Viniferin
Product Name Viniferin
CAS No.: 253435-07-3
Catalog No.: CFN92854
Molecular Formula: C28H22O6
Molecular Weight: 454.1 g/mol
Purity: >=98%
Type of Compound: Phenols
Physical Desc.: Powder
Targets: NO | PGE | NOS | COX | NF-kB | PI3K | Akt | Nrf2 | HO-1 | P450 (e.g. CYP17)
Source: The herbs of Gnetum montanum
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
α-Viniferin has anti-oxidant and anticancer activities, it strongly inhibits the activities of the two CYPs dose dependently. α-Viniferin suppresses the expression of proinflammatory genes iNOS and COX-2 in the early stage of inflammation by inhibiting the Akt/PI3K-dependent NF-κB activation and inhibits the production of proinflammatory mediators NO and PGE2 in the late stage by stimulating Nrf2-mediated HO-1 signaling pathway in LPS-stimulated BV2 microglial cells. ɛ-Viniferin and vincristine can enhance the anti-tumor effects efficiently by inducing HepG2 cell apoptosis.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • J Enzyme Inhib Med Chem.2019, 34(1):134-143
  • Korean J Environ Agric.2018, 37(4):260-267
  • Universidade Estadual Paulista2017, 42785
  • Jour. of Stored Pro & Postharvest Res.2016, 7(3):32-36
  • Academic J of Second Military Medical University2019, 40(1)
  • Cell Chem Biol.2019, 26(1):27-34
  • Front Pharmacol.2019, 10:1025
  • Phytochemistry Letters2015, 243-247
  • J Agric Food Chem.2015, 63(44):9869-78
  • Phytomedicine.2019, 55:229-237
  • Alboctalol

    Catalog No: CFN97075
    CAS No: 62394-00-7
    Price: Inquiry(manager@chemfaces.com)
    Viniferin

    Catalog No: CFN92854
    CAS No: 253435-07-3
    Price: Inquiry(manager@chemfaces.com)
    Gnetin D

    Catalog No: CFN92423
    CAS No: 84870-53-1
    Price: $468/5mg
    Shegansu B

    Catalog No: CFN92424
    CAS No: 291535-65-4
    Price: Inquiry(manager@chemfaces.com)
    Bisisorhapontigenin A

    Catalog No: CFN92592
    CAS No: 865474-98-2
    Price: Inquiry(manager@chemfaces.com)
    Pallidol

    Catalog No: CFN92341
    CAS No: 105037-88-5
    Price: $318/10mg
    Gnetulin

    Catalog No: CFN92444
    CAS No: 152340-24-4
    Price: Inquiry(manager@chemfaces.com)
    Leachianol G

    Catalog No: CFN95146
    CAS No: 164204-62-0
    Price: $368/5mg
    Leachianol F

    Catalog No: CFN95147
    CAS No: 164123-50-6
    Price: $318/5mg
    Ampelopsin F

    Catalog No: CFN92340
    CAS No: 151487-08-0
    Price: $413/5mg
    OMICS. 2014 May;18(5):324-34.
    Towards novel anti-tumor strategies for hepatic cancer: ɛ-viniferin in combination with vincristine displays pharmacodynamic synergy at lower doses in HepG2 cells.[Pubmed: 24341688]
    We investigated the anti-tumor effect of ɛ-Viniferin alone, and the putative synergy of ɛ-Viniferin with vincristine on the growth of HepG2 cells in vitro.
    METHODS AND RESULTS:
    Growth inhibition and apoptosis induction were determined by MTT assay and annexin V/propidium iodide (PI), respectively. Morphological changes and DNA fragmentation were investigated under electron microscopy and by agarose gel electrophoresis, respectively. The results collectively showed that treating cells with ɛ-Viniferin and vincristine significantly inhibited cell viability at lower doses as compared to each agent applied alone. IC(50) values for ɛ-Viniferin and vincristine were determined as 98.3 and 52.5 μM at 24 h, respectively. IC(50) value of ɛ-Viniferin in combination with vincristine was 15.8+11.25 μM (mean/SD) at 24 h. The viability of cells treated with 17.9 μM vincristine alone for 24 h was 79.62%; it reduced to 26.53% when 25 μM ɛ-Viniferin was added in combination with vincristine (p<0.05). We found that combination of drugs promoted the sensitivity of cells against to vincristine treatment.
    CONCLUSIONS:
    This study thus suggests that low concentrations of ɛ-Viniferin and vincristine can enhance the anti-tumor effects efficiently by inducing HepG2 cell apoptosis.
    Nat Prod Commun. 2015 Jun;10(6):1017-8.
    Synthesis of ε-Viniferin Glycosides by Glucosyltransferase from Phytolacca americana and their Inhibitory Activity on Histamine Release from Rat Peritoneal Mast Cells.[Pubmed: 26197540]

    METHODS AND RESULTS:
    Glycosylation of (+)-ε-Viniferin was investigated using glucosyltransferase from Phytolacca americana (PaGT3) as a biocatalyst. (+)-ε-Viniferin was converted by PaGT3 into its 4b- and 13b-β-D-glucosides, the inhibitory activities on histamine release from rat peritoneal mast cells of which were higher than that of (+)-ε-Viniferin.
    Cell Immunol. 2014 Jul;290(1):21-9.
    Anti-inflammatory mechanism of α-viniferin regulates lipopolysaccharide-induced release of proinflammatory mediators in BV2 microglial cells.[Pubmed: 24859013]
    α-Viniferin is an oligostilbene of trimeric resveratrol and has anticancer activity; however, the molecular mechanism underlying the anti-inflammatory effects of α-Viniferin has not been completely elucidated thus far. Therefore, we determined the mechanism by which α-Viniferin regulates lipopolysaccharide (LPS)-induced expression of proinflammatory mediators in BV2 microglial cells.
    METHODS AND RESULTS:
    Treatment with α-Viniferin isolated from Clematis mandshurica decreased LPS-induced production of nitric oxide (NO) and prostaglandin E2 (PGE2). α-Viniferin also downregulated the LPS-induced expression of proinflammatory genes such as iNOS and COX-2 by suppressing the activity of nuclear factor kappa B (NF-κB) via dephosphorylation of Akt/PI3K. Treatment with a specific NF-κB inhibitor, pyrrolidine dithiocarbamate (PDTC), indirectly showed that NF-κB is a crucial transcription factor for expression of these genes in the early stage of inflammation. Additionally, our results indicated that α-Viniferin suppresses NO and PGE2 production in the late stage of inflammation through induction of heme oxygenase-1 (HO-1) regulated by nuclear factor erythroid 2-related factor (Nrf2).
    CONCLUSIONS:
    Taken together, our data indicate that α-Viniferin suppresses the expression of proinflammatory genes iNOS and COX-2 in the early stage of inflammation by inhibiting the Akt/PI3K-dependent NF-κB activation and inhibits the production of proinflammatory mediators NO and PGE2 in the late stage by stimulating Nrf2-mediated HO-1 signaling pathway in LPS-stimulated BV2 microglial cells. These results suggest that α-Viniferin may be a potential candidate to regulate LPS-induced inflammation.
    Food Chem Toxicol. 2014 Jul;69:276-80.
    Potent inhibitory effect of alpha-viniferin on human cytochrome P450.[Pubmed: 24769006]
    α-Viniferin isolated from Caragana chamlagu is a trimer of resveratrol, and has several biological activities, which include anti-inflammatory, anti-oxidant, anti-arthritis, and anti-tumor activities. Herb-drug interactions are the source of the most harmful complications in patients coadministered herbal and modern medicines, and are caused by modulation of the activities of drug metabolizing enzymes.
    METHODS AND RESULTS:
    Here, the authors investigated the inhibitory effects of α-Viniferin on the activities of 9 human cytochrome P450 (CYP) isoforms using a cocktail of probe substrates and LC-MS/MS in pooled human liver microsomes (HLMs). α-Viniferin strongly inhibited 7 of the 9 CYP isoforms (except CYP2A6 and CYP2E1). Furthermore, α-Viniferin strongly inhibited CYP2C19-mediated omeprazole 5-hydroxylation and CYP3A4-catalyzed midazolam 1-hydroxylation with IC50 values of 0.93 and 1.2 μM, respectively. α-Viniferin strongly inhibited the activities of these two CYPs dose dependently, but not time-dependently.
    CONCLUSIONS:
    Lineweaver-Burk plots and secondary plots indicated a typical pattern of mix-mode inhibition for CYP2C19 and 3A4. This is the first investigation conducted on the inhibitory effect of α-Viniferin on CYP2C19 and 3A4 in HLMs to predict a potential herb-drug interaction.
    Arjunic acid

    Catalog No: CFN98397
    CAS No: 31298-06-3
    Price: $318/5mg
    Curzerenone

    Catalog No: CFN92027
    CAS No: 20493-56-5
    Price: $258/10mg
    Piplartine

    Catalog No: CFN96137
    CAS No: 20069-09-4
    Price: $100/20mg
    Eudesmin

    Catalog No: CFN96266
    CAS No: 526-06-7
    Price: $188/20mg
    Matairesinoside

    Catalog No: CFN89301
    CAS No: 23202-85-9
    Price: $288/5mg
    Arjungenin

    Catalog No: CFN95039
    CAS No: 58880-25-4
    Price: $318/10mg
    Tectol

    Catalog No: CFN91054
    CAS No: 2449-39-6
    Price: $338/10mg
    Yuanhunine

    Catalog No: CFN95179
    CAS No: 104387-15-7
    Price: $368/5mg
    Neochlorogenic acid methyl ester

    Catalog No: CFN95190
    CAS No: 123410-65-1
    Price: $198/5mg
    Licoflavanone

    Catalog No: CFN95213
    CAS No: 119240-82-3
    Price: $413/5mg